.@AdialPharma announced the acquisition of @AzoraTx, bringing AT177, a colon-targeted AhR agonist, into its pipeline. The transaction is supported by a concurrent private placement of up to $64M, including $32M upfront and potential additional milestone tranches.
Adial will host a call and webcast today, June 11, 2026, at 1:00 pm ET to discuss the acquisition and financing. Dial-in: 1-877-451-6152 domestic / 1-201-389-0879 international; passcode 13761153. Webcast: bit.ly/4ejzOf5
Read more: bit.ly/3Q8x0cB$ADIL#Acquisition#PrivatePlacement#CorporateDevelopment